In the last trading session, 1.05 million Cellectar Biosciences Inc (NASDAQ:CLRB) shares changed hands as the company’s beta touched 0.52. With the company’s per share price at $0.26 changed hands at $0.0 or 3.33% during last session, the market valuation stood at $12.16M. CLRB’s last price was a discount, traded about -1215.38% off its 52-week high of $3.42. The share price had its 52-week low at $0.22, which suggests the last value was 15.38% up since then.
Analysts gave the Cellectar Biosciences Inc (CLRB) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.33. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CLRB as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Cellectar Biosciences Inc (NASDAQ:CLRB) trade information
Instantly CLRB was in green as seen at the end of in last trading. With action 10.00%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -11.71%, with the 5-day performance at 10.00% in the green. However, in the 30-day time frame, Cellectar Biosciences Inc (NASDAQ:CLRB) is -9.03% down.
The consensus price target for the stock as assigned by Wall Street analysts is 12, meaning bulls need an upside of 97.83% from its current market value. According to analyst projections, CLRB’s forecast low is 12 with 12 as the target high. To hit the forecast high, the stock’s price needs a -4515.38% plunge from its current level, while the stock would need to soar -4515.38% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 40.27%. The 2025 estimates are for Cellectar Biosciences Inc earnings to increase by 53.01%, but the outlook for the next 5-year period is at 19.07% per year.
CLRB Dividends
Cellectar Biosciences Inc is expected to release its next quarterly earnings report in June.
ROSALIND ADVISORS, INC. holds the second largest percentage of outstanding shares, with 7.5535% or 2.71 million shares worth $6.76 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 1.07 shares estimated at $0.28 million under it, the former controlled 2.33% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 1.23% of the shares, roughly 568.75 shares worth around $0.15 million.
